Long-term high fat feeding of rats results in increased numbers of circulating microvesicles with pro-inflammatory effects on endothelial cells.
暂无分享,去创建一个
C. Lawson | L F Heinrich | D K Andersen | M E Cleasby | C Lawson | M. Cleasby | D. Andersen | L. F. Heinrich
[1] Paul Harrison,et al. Classification, Functions, and Clinical Relevance of Extracellular Vesicles , 2012, Pharmacological Reviews.
[2] Françoise Dignat-George,et al. The Many Faces of Endothelial Microparticles , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[3] M. Alessi,et al. Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1. , 2007, The American journal of pathology.
[4] R Lacroix,et al. Standardization of pre‐analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop , 2013, Journal of thrombosis and haemostasis : JTH.
[5] P. Libby,et al. Immune effector mechanisms implicated in atherosclerosis: from mice to humans. , 2013, Immunity.
[6] R. Pink,et al. Routes and mechanisms of extracellular vesicle uptake , 2014, Journal of extracellular vesicles.
[7] S. Son. Reactive Oxygen and Nitrogen Species in Pathogenesis of Vascular Complications of Diabetes , 2012, Diabetes & metabolism journal.
[8] M. Cybulsky,et al. Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. , 1999, Circulation research.
[9] P. Nusbaum,et al. Distinct Signaling Pathways Are Involved in Leukosialin (CD43) Down-regulation, Membrane Blebbing, and Phospholipid Scrambling during Neutrophil Apoptosis* , 2005, Journal of Biological Chemistry.
[10] L. Ragolia,et al. Circulating Endothelial Microparticles in Diabetes Mellitus , 2010, Mediators of inflammation.
[11] G. King,et al. The role of protein kinase C activation and the vascular complications of diabetes. , 2007, Pharmacological research.
[12] G. Holtrop,et al. Platelet-derived microparticle count and surface molecule expression differ between subjects with and without type 2 diabetes, independently of obesity status , 2014, Journal of Thrombosis and Thrombolysis.
[13] G. Pasterkamp,et al. Extracellular vesicle markers in relation to obesity and metabolic complications in patients with manifest cardiovascular disease , 2014, Cardiovascular Diabetology.
[14] C. Théry,et al. Membrane vesicles as conveyors of immune responses , 2009, Nature Reviews Immunology.
[15] Chantal M Boulanger,et al. Microparticles From Human Atherosclerotic Plaques Promote Endothelial ICAM-1–Dependent Monocyte Adhesion and Transendothelial Migration , 2011, Circulation research.
[16] S. Faure,et al. Microparticles from Patients with Metabolic Syndrome Induce Vascular Hypo-Reactivity via Fas/Fas-Ligand Pathway in Mice , 2011, PloS one.
[17] D. Connor,et al. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib , 2010, Thrombosis and Haemostasis.
[18] P. Schauer,et al. Restoration of glycemic control in patients with type 2 diabetes mellitus after bariatric surgery is associated with reduction in microparticles. , 2013, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.
[19] M. Zarrindast,et al. Elevated CSF and plasma microparticles in a rat model of streptozotocin-induced cognitive impairment , 2013, Behavioural Brain Research.
[20] J. Millán,et al. TNF-induced endothelial barrier disruption: beyond actin and Rho , 2014, Thrombosis and Haemostasis.
[21] Yu Luo,et al. Plasma Endothelial Microparticles and Their Correlation With the Presence of Hypertension and Arterial Stiffness in Patients With Type 2 Diabetes , 2012, Journal of clinical hypertension.
[22] J. Usherwood,et al. Microparticle formation after co‐culture of human whole blood and umbilical artery in a novel in vitro model of flow , 2012, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[23] D. Yellon,et al. Exosomes: Nanoparticles Involved in Cardioprotection? , 2014, Circulation research.
[24] Robert J Freishtat,et al. Adipocyte-derived Exosomal miRNAs: A Novel Mechanism for Obesity-Related Disease , 2014, Pediatric Research.
[25] A. Chait,et al. Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies , 2008, The Lancet.
[26] M. Macey,et al. Microparticle formation after exposure of blood to activated endothelium under flow , 2010, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[27] S M Grundy,et al. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. , 1999, Circulation.
[28] B. Spiegelman,et al. IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance , 1996, Science.
[29] Philip Greenland,et al. Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations , 1999 .
[30] R. Schiffelers,et al. Toward routine detection of extracellular vesicles in clinical samples , 2014, International journal of laboratory hematology.
[31] Y. Zou,et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. , 1994, The Journal of biological chemistry.
[32] Tatiane Mieko de Meneses Fujii,et al. A high-fat diet increases interleukin-3 and granulocyte colony-stimulating factor production by bone marrow cells and triggers bone marrow hyperplasia and neutrophilia in wistar rats , 2013, Experimental biology and medicine.
[33] R. Fernandes,et al. Metformin restores endothelial function in aorta of diabetic rats , 2011, British journal of pharmacology.
[34] N. Ruderman,et al. Protein Kinase C-&bgr; Contributes to Impaired Endothelial Insulin Signaling in Humans With Diabetes Mellitus , 2012, Circulation.
[35] R. Nieuwland,et al. Elevated Numbers of Tissue-Factor Exposing Microparticles Correlate With Components of the Metabolic Syndrome in Uncomplicated Type 2 Diabetes Mellitus , 2002, Circulation.
[36] Jacqueline Capeau,et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. , 2006, European cytokine network.
[37] U. Kintscher,et al. The endothelium and vascular inflammation in diabetes , 2007, Diabetes & vascular disease research.
[38] R. Andriantsitohaina,et al. Circulating microparticles from pulmonary hypertensive rats induce endothelial dysfunction. , 2010, American journal of respiratory and critical care medicine.
[39] G. Mann,et al. Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling. , 2009, Cardiovascular research.
[40] Ming Chen,et al. Circulating level of microparticles and their correlation with arterial elasticity and endothelium-dependent dilation in patients with type 2 diabetes mellitus. , 2010, Atherosclerosis.
[41] S. Msika,et al. Microparticle increase in severe obesity: Not related to metabolic syndrome and unchanged after massive weight loss , 2013, Obesity.